Table of Contents Author Guidelines Submit a Manuscript
Multiple Sclerosis International
Volume 2015 (2015), Article ID 960282, 8 pages
http://dx.doi.org/10.1155/2015/960282
Research Article

Does Self-Efficacy Affect Cognitive Performance in Persons with Clinically Isolated Syndrome and Early Relapsing Remitting Multiple Sclerosis?

1MS4 Research Institute, Ubbergseweg 34, 6522 KJ Nijmegen, Netherlands
2Department of Community & Occupational Medicine, University Medical Center Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, Netherlands
3Swinburne University, John Street, Hawthorn, Melbourne, VIC 3122, Australia
4Medisch Centrum Alkmaar, Wilhelminalaan 12, 1815 JD Alkmaar, Netherlands
5Viecuri Medisch Centrum, Merseloseweg 130, 5801 CE Venray, Netherlands
6Westfries Gasthuis, Maelsonstraat 3, 1624 NP Hoorn, Netherlands
7St. Elisabeth Ziekenhuis, Hilvarenbeekseweg 60, 5022 GC Tilburg, Netherlands
8Reinier de Graaf Gasthuis, Reinier de Graafweg 3-11, 2625 AD Delft, Netherlands
9Medisch Centrum Leeuwarden, Henri Dunantweg 2, 8934 AD Leeuwarden, Netherlands
10Department of Experimental Psychology, Utrecht University, Heidelberglaan 2, 3584 CS Utrecht, Netherlands
11Zuwe Hofpoort Ziekenhuis, Regionaal Psychiatrisch Centrum Woerden, Polanerbaan 2, 3447 GN Woerden, Netherlands

Received 8 February 2015; Accepted 15 April 2015

Academic Editor: Angelo Ghezzi

Copyright © 2015 Peter Joseph Jongen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Clerico, F. Faggiano, J. Palace, G. Rice, M. Tintorè, and L. Durelli, “Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD005278, 2008. View at Google Scholar · View at Scopus
  2. M. Trojano, F. Pellegrini, A. Fuiani et al., “New natural history of interferon-β-treated relapsing multiple sclerosis,” Annals of Neurology, vol. 61, no. 4, pp. 300–306, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Uitdehaag, C. Constantinescu, P. Cornelisse et al., “Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study,” Therapeutic Advances in Neurological Disorders, vol. 4, no. 1, pp. 3–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Bandura, Social Foundations of Thought and Action: A Social Cognitive Theory, Prentice-Hall, Englewood Cliffs, NJ, USA, 1986.
  5. D. Amtmann, A. M. Bamer, K. F. Cook, R. L. Askew, V. K. Noonan, and J. A. Brockway, “University of Washington self-efficacy scale: A new self-efficacy scale for people with disabilities,” Archives of Physical Medicine and Rehabilitation, vol. 93, no. 10, pp. 1757–1765, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Bandura, “Self-efficacy: toward a unifying theory of behavioral change,” Psychological Review, vol. 84, no. 2, pp. 191–215, 1977. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Bandura, “Self-efficacy,” in Encyclopedia of Human Behavior, V. S. Ramachaudran, Ed., vol. 4, p. 71, Academic Press, New York, NY, USA, 1994. View at Google Scholar
  8. Z. M. Shnek, F. W. Foley, N. G. LaRocca et al., “Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury,” Annals of Behavioral Medicine, vol. 19, no. 3, pp. 287–294, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. E. McAuley, R. W. Motl, K. S. Morris et al., “Enhancing physical activity adherence and well-being in multiple sclerosis: a randomised controlled trial,” Multiple Sclerosis, vol. 13, no. 5, pp. 652–659, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. E. M. Snook and R. W. Motl, “Physical activity behaviors in individuals with multiple sclerosis: roles of overall and specific symptoms, and self-efficacy,” Journal of Pain and Symptom Management, vol. 36, no. 1, pp. 46–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. R. W. Motl, E. M. Snook, E. McAuley, and R. C. Gliottoni, “Symptoms, self-efficacy, and physical activity among individuals with multiple sclerosis,” Research in Nursing & Health, vol. 29, no. 6, pp. 597–606, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. K. S. Morris, E. McAuley, and R. W. Motl, “Self-efficacy and environmental correlates of physical activity among older women and women with multiple sclerosis,” Health Education Research, vol. 23, no. 4, pp. 744–752, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Ferrier, N. Dunlop, and C. Blanchard, “The role of outcome expectations and self-efficacy in explaining physical activity behaviors of individuals with multiple sclerosis,” Behavioral Medicine, vol. 36, no. 1, pp. 7–11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. R. W. Motl and E. M. Snook, “Physical activity, self-efficacy, and quality of life in multiple sclerosis,” Annals of Behavioral Medicine, vol. 35, no. 1, pp. 111–115, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A. K. Stuifbergen, H. Becker, S. Blozis, G. Timmerman, and V. Kullberg, “A randomized clinical trial of a wellness intervention for women with multiple sclerosis,” Archives of Physical Medicine and Rehabilitation, vol. 84, no. 4, pp. 467–476, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Riazi, A. J. Thompson, and J. C. Hobart, “Self-efficacy predicts self-reported health status in multiple sclerosis,” Multiple Sclerosis, vol. 10, no. 1, pp. 61–66, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. A. M. Barnwell and D. J. Kavanagh, “Prediction of psychological adjustment to multiple sclerosis,” Social Science and Medicine, vol. 45, no. 3, pp. 411–418, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. D. W. Langdon, “Cognition in multiple sclerosis,” Current Opinion in Neurology, vol. 24, no. 3, pp. 244–249, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. R. S. Prakash, E. M. Snook, J. M. Lewis, R. W. Motl, and A. F. Kramer, “Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis,” Multiple Sclerosis, vol. 14, no. 9, pp. 1250–1261, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. S. V. Paunonen and R. Y. Hong, “Self-efficacy and the prediction of domain-specific cognitive abilities,” Journal of Personality, vol. 78, no. 1, pp. 339–360, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. P. J. Jongen, K. Wesnes, B. van Geel et al., “Relationship between working hours and power of attention, memory, fatigue, depression and self-efficacy one year after diagnosis of clinically isolated syndrome and relapsing remitting multiple sclerosis,” PLoS ONE, vol. 9, no. 5, Article ID e96444, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. C. H. Polman, S. C. Reingold, G. Edan et al., “Diagnostic criteria for multiple sclerosis: 2005 Revisions to the ‘McDonald Criteria’,” Annals of Neurology, vol. 58, no. 6, pp. 840–846, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. C. E. Schwartz, L. Coulthard-Morris, Q. Zeng, and P. Retzlaff, “Measuring self-efficacy in people with multiple sclerosis: a validation study,” Archives of Physical Medicine and Rehabilitation, vol. 77, no. 4, pp. 394–398, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. K. A. Wesnes, I. McKeith, C. Edgar, M. Emre, and R. Lane, “Benefits of rivastigmine on attention in dementia associated with Parkinson disease,” Neurology, vol. 65, no. 10, pp. 1654–1656, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. K. A. Wesnes, C. Edgar, A. D. P. Dean, and S. J. Wroe, “The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy,” Epilepsy and Behavior, vol. 14, no. 3, pp. 522–528, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Edgar, P. J. Jongen, E. Sanders et al., “Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery,” BMC Neurology, vol. 11, article 68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. P. G. Ritvo, J. Fischer, D. Miller, H. Andrews, D. W. Paty, and N. G. LaRocca, Multiple Sclerosis Quality of Life Inventory (MSQLI): A User's Manual, National Multiple Sclerosis Society, New York, NY, USA, 1997.
  28. J. D. Fisk, P. G. Ritvo, L. Ross, D. A. Haase, T. J. Marrie, and W. F. Schlech, “Measuring the functional impact of fatigue: initial validation of the fatigue impact scale,” Clinical Infectious Diseases, vol. 18, supplement 1, pp. S79–S83, 1994. View at Publisher · View at Google Scholar · View at Scopus
  29. A. T. Beck, W. Y. Rial, and K. Rickels, “Short form of depression inventory: cross validation,” Psychological Reports, vol. 34, no. 3, pp. 1184–1186, 1974. View at Google Scholar · View at Scopus
  30. P. J. Moran and D. C. Mohr, “The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis,” Journal of Behavioral Medicine, vol. 28, no. 1, pp. 35–41, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Hobart, D. Lamping, R. Fitzpatrick, A. Riazi, and A. Thompson, “The multiple sclerosis impact scale (MSIS-29) a new patient-based outcome measure,” Brain, vol. 124, no. 5, pp. 962–973, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. C. McGuigan and M. Hutchinson, “The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 75, no. 2, pp. 266–269, 2004. View at Google Scholar · View at Scopus
  33. J. F. Kurtzke, “Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS),” Neurology, vol. 33, no. 11, pp. 1444–1452, 1983. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Zhang, E. Waubant, G. Cutter, J. S. Wolinsky, and R. Glanzman, “EDSS variability before randomization may limit treatment discovery in primary progressive MS,” Multiple Sclerosis, vol. 19, no. 6, pp. 775–781, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. R. W. Motl, E. McAuley, S. Doerksen, L. Hu, and K. S. Morris, “Preliminary evidence that self-efficacy predicts physical activity in multiple sclerosis,” International Journal of Rehabilitation Research, vol. 32, no. 3, pp. 260–263, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. S. L. Kasser and M. Kosma, “Health beliefs and physical activity behavior in adults with multiple sclerosis,” Disability and Health Journal, vol. 5, no. 4, pp. 261–268, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. T. V. Perneger, “What's wrong with Bonferroni adjustments,” British Medical Journal, vol. 316, no. 7139, pp. 1236–1238, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. K. J. Rothman, “No adjustments are needed for multiple comparisons,” Epidemiology, vol. 1, no. 1, pp. 43–46, 1990. View at Publisher · View at Google Scholar · View at Scopus
  39. P. J. Jongen, D. Lehnick, J. Koeman et al., “Fatigue and health-related quality of life in relapsing-remitting multiple sclerosis after 2 years glatiramer acetate treatment are predicted by changes at 6 months: an observational multi-center study,” Journal of Neurology, vol. 261, no. 8, pp. 1469–1476, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. B. R. Payne, J. J. Jackson, P. L. Hill, X. Gao, B. W. Roberts, and E. A. L. Stine-Morrow, “Memory self-efficacy predicts responsiveness to inductive reasoning training in older adults,” Journals of Gerontology Series B: Psychological Sciences and Social Sciences, vol. 67, no. 1, pp. 27–35, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. J. R. Themanson and P. J. Rosen, “Examining the relationships between self-efficacy, task-relevant attentional control , and task performance: evidence from event-related brain potentials,” British Journal of Psychology, vol. 106, no. 2, pp. 253–271, 2015. View at Publisher · View at Google Scholar